0000000000843734

AUTHOR

Beretta S.

showing 2 related works from this author

The state of stroke services across the globe: Report of World Stroke Organization–World Health Organization surveys

2021

Background Improving stroke services is critical for reducing the global stroke burden. The World Stroke Organization–World Health Organization– Lancet Neurology Commission on Stroke conducted a survey of the status of stroke services in low and middle-income countries (LMICs) compared to high-income countries. Methods Using a validated World Stroke Organization comprehensive questionnaire, we collected and compared data on stroke services along four pillars of the stroke quadrangle (surveillance, prevention, acute stroke, and rehabilitation) in 84 countries across World Health Organization regions and economic strata. The World Health Organization also conducted a survey of non-communicabl…

Gerontologymedicine.medical_specialtymedicine.medical_treatmentmedia_common.quotation_subjectGlobeCommissionstroke quadrangleGlobal HealthWorld Health OrganizationWorld healthArticleStroke servicerehabilitationlow and middle-income countrie03 medical and health sciences0302 clinical medicineState (polity)preventionAcute careSurveys and QuestionnairesmedicineHumans030212 general & internal medicinehigh-income countrieStrokeDeveloping Countriesmedia_commonStroke servicesRehabilitationbusiness.industryStroke Rehabilitationmedicine.disease3. Good healthStrokemedicine.anatomical_structureNeurologylow- and middle-income countrieSettore MED/26 - Neurologiaacute carebusiness030217 neurology & neurosurgery
researchProduct

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)

2021

In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Studies performed in a naturalistic setting are a useful complement to characterize the drug profile.This multicentre study assessed the effectiveness and tolerability of adjunctive BRV in a large population of patients with focal epilepsy in the context of real-world clinical practice.The BRIVAFIRST (BRIVAracetam add-on First Italian netwoRk STudy) was a retrospective, multicentre study including adult patients prescribed adjunctive BRV. Patients with focal epilepsy and 12-month follow-up were considered. Main outcomes included the rates of seizure-freedom, s…

AdultMaleDrug Resistant EpilepsyLevetiracetamEpilepsy CNS therapyCorrectionMiddle AgedSettore MED/26PyrrolidinonesPsychiatry and Mental healthTreatment OutcomeItalyChemotherapy AdjuvantHumansPharmacology (medical)AnticonvulsantsFemaleNeurology (clinical)Epilepsies PartialRetrospective Studies
researchProduct